Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma
Gynecologic and Obstetric Investigation Nov 30, 2017
Önalan G, et al. - Researchers here assessed the effects of a tumor necrosis factor inhibitor (etanercept) on pregnancy outcomes in patients with endometrioma who were treated with assisted reproductive technology. Findings suggested that etanercept could be a new non-hormonal therapy that might be an adjunct to treatment of infertile women with endometrioma. However, full clarification regarding the safety of etanercept on embryos and fetuses requires exploration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries